Type 1 diabetes mellitus (T1DM) is characterized by C-peptide deficiency and elevated levels of pro-inflammatory cytokines. The aim of this study was to investigate the role of C-peptide in renal and inflammatory complications in streptozotocin (STZ)-diabetic mice model of T1DM with kidney disease. The study was performed in 8-week old male C57BL/6 mice. Two streptozotocin-diabetic groups (a T1DM animal model), after 4 weeks of diabetes, were treated with subcutaneous infusion of either vehicle (n = 12) or C-peptide (n = 11). Two non-diabetic groups (vehicle, n = 10; C-peptide, n = 9) were treated using the same protocol as described for the diabetic mice. The treatment with C-peptide in the diabetic group reduced the urinary levels of IL17 and TNFα, as well as IL4 and IL10 (p < 0.05). Contrary, the diabetic + C-peptide group presented higher IL10 gene expression in kidney. Besides, it displayed a reduction of TNFα gene expression. The data suggest that C-peptide may modulate pro- and anti-inflammatory signalling pathways, resulting in attenuation of kidney inflammation in T1DM animal model.
C-peptide Type 1 diabetes mellitus Inflammation Kidney disease
This is a preview of subscription content, log in to check access.
ACSS, APF and KBG are grateful to CNPq Research Fellowship (PQ). This work was supported by FAPEMIG, CNPq/Brazil and CAPES.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
Chiang JL, Kirkman MS, Laffel LMG, Peters AL (2014) Type 1 diabetes through the life span: a position statement of the American Diabetes Association. Diabetes Care 37:2034–2054CrossRefGoogle Scholar
Luppi P, Kallas A, Wahren J (2013) Can C-peptide mediated anti-inflammatory effects retard the development of microvascular complications of type 1 diabetes? Diabetes Metab Res Rev 29:357–362CrossRefGoogle Scholar
Sanchez-Zamora YI, Juarez-Avelar I, Vazquez-Mendoza A, Hiriart M, Rodriguez-Sosa M (2016) Altered macrophage and dendritic cell response in Mif −/− mice reveals a role of Mif for inflammatory-Th1 response in type 1 diabetes. J Diabetes Res 2016:7053963CrossRefGoogle Scholar
Navarro-González JF, Mora-Fernández C, Muros de Fuentes M, García-Pérez J (2011) Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy. Nat Rev Nephrol 7(6):327–340CrossRefGoogle Scholar
DiPetrillo K, Coutermarsh B, Gesek FA (2003) Urinary tumor necrosis factor contributes to sodium retention and renal hypertrophy during diabetes. Am J Physiol Renal Physiol 284:F113–F121CrossRefGoogle Scholar
Steiner DF, Cunningham D, Spigelman L, Aten B (1967) Insulin biosynthesis: evidence for a precursor. Science 157(789):697–700CrossRefGoogle Scholar
Johansson BL, Linde B, Wahren J (1992) Effects of C-peptide on blood flow, capillary diffusion capacity and glucose utilization in the exercising forearm of type 1 (insulin-dependent) diabetic patients. Diabetologia 35:1151–1158CrossRefGoogle Scholar
Wahren J, Larsson C (2015) C-peptide: new findings and therapeutic possibilities. Diabetes Res Clin Pract 107:309–319CrossRefGoogle Scholar
Sun C, Sun L, Ma H, Peng J, Zhen Y, Duan K et al (2012) The phenotype and functional alterations of macrophages in mice with hyperglycemia for long term. J Cell Physiol 227(4):1670–1679CrossRefGoogle Scholar
Driessler F, Venstrom K, Sabat R, Asadullah K, Schottelius AJ (2004) Molecular mechanisms of interleukin-10-mediated inhibition of NF-κB activity: a role for p50. Clin Exp Immunol 135(1):64–73CrossRefGoogle Scholar
Uhde A, Ciurkiewicz M, Herder V, Khan MA, Hensel N, Claus P et al (2018) Intact interleukin-10 receptor signaling protects from hippocampal damage elicited by experimental neurotropic virus infection of SJL mice. Sci Rep 8:6106CrossRefGoogle Scholar
Kimmel PL, Cohen DJ, Abraham AA, Bodi I, Schwartz AM, Phillips TM (2003) Upregulation of MHC class II, interferon-a and interferon-g receptor protein expression in HIV-associated nephropathy. Nephrol Dial Transplant 18:285–292CrossRefGoogle Scholar
Samnegard B, Jacobson SH, Jaremko G, Johansson BL, Ekberg K, Isaksson B et al (2005) C-peptide prevents glomerular hypertrophy and mesangial matrix expansion in diabetic rats. Nephrol Dial Transplant 20:532–538CrossRefGoogle Scholar
Sjoquist M, Huang W, Johansson BL (1998) Effects of C-peptide on renal function at the early stage of experimental diabetes. Kidney Int 54:758–764CrossRefGoogle Scholar
Flynn E, Lee J, Hutchens Z, Chade A, Maric-Bilkan C (2013) C-peptide preserves the renal microvascular architecture in the streptozotocin-induced diabetic rat. J Diabetes Complicat 27:538–547CrossRefGoogle Scholar